SRC
MBOT icon

Shufro Rose & Co’s Microbot Medical MBOT Stock Holding History

Shufro Rose & Co’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6
Closed -$3K – 272
2016
Q1 		$3K Hold
6
– – ﹤0.01% 273
2015
Q4 		$4K Hold
6
– – ﹤0.01% 259
2015
Q3 		$4K Hold
6
– – ﹤0.01% 260
2015
Q2 		$5K Buy
+6
New +$7.06K ﹤0.01% 261

Other funds holding MBOT

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Shufro Rose & Co's MBOT Position: Q2 2016 in Review

Shufro Rose & Co sold out of Microbot Medical (MBOT) in Q2 2016, closing a stake of 6 shares — an estimated $3K sold.

Shufro Rose & Co first reported a position in MBOT in Q2 2015 and held it in 4 quarters. The position peaked at $5K in Q2 2015. 22 funds tracked by Wall St. Rank hold MBOT as of Q2 2016.

  • Shufro Rose & Co reported no remaining Microbot Medical position as of Q2 2016 after selling out during the quarter.
  • Shufro Rose & Co sold 6 Microbot Medical shares in Q2 2016, an estimated $3K.
  • Shufro Rose & Co first reported a position in Microbot Medical in Q2 2015 and held it in 4 quarters.
  • Shufro Rose & Co's Microbot Medical position peaked at $5K in Q2 2015.
  • 22 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2016.

Based on Shufro Rose & Co's 13F filing for Q2 2016, filed 5 Aug 2016.